Creative Medical Technology Statistics Share Statistics Creative Medical Technology has 2.58M
shares outstanding. The number of shares has increased by 47.64%
in one year.
Shares Outstanding 2.58M Shares Change (YoY) 47.64% Shares Change (QoQ) -0.19% Owned by Institutions (%) 0.23% Shares Floating 2.18M Failed to Deliver (FTD) Shares 1,977 FTD / Avg. Volume 1.44%
Short Selling Information The latest short interest is 100.36K, so 3.89% of the outstanding
shares have been sold short.
Short Interest 100.36K Short % of Shares Out 3.89% Short % of Float 3.95% Short Ratio (days to cover) 3.94
Valuation Ratios The PE ratio is -0.62 and the forward
PE ratio is -1.12.
Creative Medical Technology's PEG ratio is
0.47.
PE Ratio -0.62 Forward PE -1.12 PS Ratio 310.89 Forward PS 0.4 PB Ratio 0.54 P/FCF Ratio -0.65 PEG Ratio 0.47
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Creative Medical Technology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 18.73,
with a Debt / Equity ratio of 0.
Current Ratio 18.73 Quick Ratio 18.72 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $2.75K Profits Per Employee $-1.37M Employee Count 4 Asset Turnover 0 Inventory Turnover 2.01
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 7.67% in the
last 52 weeks. The beta is 5.22, so Creative Medical Technology's
price volatility has been higher than the market average.
Beta 5.22 52-Week Price Change 7.67% 50-Day Moving Average 3.22 200-Day Moving Average 2.88 Relative Strength Index (RSI) 46.78 Average Volume (20 Days) 137,317
Income Statement In the last 12 months, Creative Medical Technology had revenue of 11K
and earned -5.49M
in profits. Earnings per share was -3.71.
Revenue 11K Gross Profit 6.6K Operating Income -5.74M Net Income -5.49M EBITDA -5.63M EBIT -5.74M Earnings Per Share (EPS) -3.71
Full Income Statement Balance Sheet The company has 5.94M in cash and 14.19K in
debt, giving a net cash position of 5.93M.
Cash & Cash Equivalents 5.94M Total Debt 14.19K Net Cash 5.93M Retained Earnings -64.59M Total Assets 7.11M Working Capital 6.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.3M
and capital expenditures 0, giving a free cash flow of -5.3M.
Operating Cash Flow -5.3M Capital Expenditures n/a Free Cash Flow -5.3M FCF Per Share -3.58
Full Cash Flow Statement Margins Gross margin is 60%, with operating and profit margins of -52216.92% and -49940.74%.
Gross Margin 60% Operating Margin -52216.92% Pretax Margin -49940.74% Profit Margin -49940.74% EBITDA Margin -51212.81% EBIT Margin -52216.92% FCF Margin -48193.56%
Dividends & Yields CELZ does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for CELZ.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 12, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jun 12, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 4.47 Piotroski F-Score 3
